Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other financing activities (2023 - 2024)

Historic Other financing activities for 60 Degrees Pharmaceuticals (SXTP) over the last 2 years, with Q3 2024 value amounting to $96217.0.

  • 60 Degrees Pharmaceuticals' Other financing activities fell 1184.72% to $96217.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $480583.0, marking a year-over-year change of. This contributed to the annual value of $528926.0 for FY2023, which is 67070.33% up from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Other financing activities stood at $96217.0 for Q3 2024, which was down 1184.72% from -$10357.0 recorded in Q2 2024.
  • 60 Degrees Pharmaceuticals' Other financing activities' 5-year high stood at $378506.0 during Q4 2023, with a 5-year trough of -$10357.0 in Q2 2024.